Sign In
Buy LLY
$1,083.23
+18.39 (+1.73%)
At Close: Jun 03, 2026
Core Alternative Capital Cuts Stock Position in Eli Lilly and Company $LLY
08:14am, Wednesday, 28'th Jan 2026
Core Alternative Capital trimmed its holdings in shares of Eli Lilly and Company (NYSE: LLY) by 10.0% in the third quarter, according to the company in its most recent filing with the Securities and E
First Look: Amazon, UPS cuts; ASML surges; Fed in focus
07:38am, Wednesday, 28'th Jan 2026
Stock News Amazon trims 16,000 corporate roles: Amazon (AMZN) announced a second round of layoffs in three months, cutting ~16,000 roles as it streamlines layer
Eli Lilly signs up to $1.12 billion deal with private gene-editing firm Seamless
07:02am, Wednesday, 28'th Jan 2026
U.S. drugmaker Eli Lilly signed an agreement worth up to $1.12 billion with Seamless Therapeutics, the Germany-based startup said on Wednesday, to develop and commercialize treatments for hearing loss
Exane Asset Management Decreases Stock Holdings in Eli Lilly and Company $LLY
07:00am, Wednesday, 28'th Jan 2026
Exane Asset Management lowered its holdings in shares of Eli Lilly and Company (NYSE: LLY) by 97.7% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Excha
EPG Wealth Management LLC Raises Holdings in Eli Lilly and Company $LLY
06:22am, Wednesday, 28'th Jan 2026
EPG Wealth Management LLC lifted its position in shares of Eli Lilly and Company (NYSE: LLY) by 10.0% during the third quarter, according to its most recent filing with the Securities and Exchange Com
Eli Lilly partners with Seamless Therapeutics on gene editing treatments for hearing loss
06:21am, Wednesday, 28'th Jan 2026
Eli Lilly and Co (NYSE:LLY) announced that it has entered a strategic global research collaboration and licensing agreement with Seamless Therapeutics to...
Eli Lilly and Company (LLY) Projected to Post Earnings on Wednesday
05:16am, Wednesday, 28'th Jan 2026
Eli Lilly and Company (NYSE: LLY - Get Free Report) will likely be posting its Q4 2025 results before the market opens on Wednesday, February 4th. Analysts expect the company to announce earnings of $
US Medicare names Eli Lilly, Pfizer and AbbVie drugs for next Medicare price talks
04:52pm, Tuesday, 27'th Jan 2026
The U.S. Centers for Medicare & Medicaid Services on Tuesday named a new group of branded drugs from major pharmaceutical companies including Eli Lilly , Pfizer and AbbVie for the third cycle of the M
Up 36%, Is Eli Lilly Still a Buy?
11:02am, Tuesday, 27'th Jan 2026
Eli Lilly is at the forefront of both diabetes and obesity medications. The pharmaceutical giant has offered strong guidance for the end of 2025.
Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It
10:00am, Tuesday, 27'th Jan 2026
Lilly (LLY) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Where Will Eli Lilly Be in 10 Years?
09:07am, Tuesday, 27'th Jan 2026
The pharmaceutical industry has a well-structured cycle. Eli Lilly is currently benefiting from the early stages of the cycle.
Eli Lilly and Company $LLY Shares Sold by Chilton Capital Management LLC
05:20am, Tuesday, 27'th Jan 2026
Chilton Capital Management LLC cut its holdings in shares of Eli Lilly and Company (NYSE: LLY) by 26.4% during the third quarter, according to its most recent Form 13F filing with the Securities and E
Eli Lilly and Company $LLY Shares Sold by Belpointe Asset Management LLC
04:46am, Tuesday, 27'th Jan 2026
Belpointe Asset Management LLC lessened its stake in Eli Lilly and Company (NYSE: LLY) by 17.0% during the undefined quarter, according to the company in its most recent filing with the Securities and
Bensler LLC Buys 740 Shares of Eli Lilly and Company $LLY
04:46am, Tuesday, 27'th Jan 2026
Bensler LLC grew its stake in Eli Lilly and Company (NYSE: LLY) by 4.1% during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The instituti
Alta Wealth Advisors LLC Sells 522 Shares of Eli Lilly and Company $LLY
03:38am, Tuesday, 27'th Jan 2026
Alta Wealth Advisors LLC lessened its position in shares of Eli Lilly and Company (NYSE: LLY) by 17.0% during the undefined quarter, according to its most recent Form 13F filing with the Securities an
